Clinical Evaluation of HIV/AIDS Patients on Antiretroviral Therapy using HIV Symptoms Index: A reliability and Applicability Evaluation using Indonesian Language

Khalid Mohammad Shidiq, Erni J Nelwan, Evy Yunihastuti, Kuntjoro Harimurti, Herdiman T Pohan

Abstract


Background: HIV/AIDS is a chronic, lifelong disease with a wide clinical spectrum which could decrease the quality of life. Objective symptoms measurement is important because it is correlated to treatment adherence and progressivity of the disease. Currently, there is no clinical tool available to evaluate symptoms of HIV infection and the treatment’s side effect for the outpatient setting. This study aimed is to assess the reliability of the Indonesian version of HIV Symptom Index for measuring symptoms of HIV/AIDS patients, and use it for assessment of their symptom profile. Methods: this is a cross sectional study in outpatient HIV/AIDS subjects (n=87) recruited in Cipto Mangunkusumo Hospital’s HIV clinic from September-November 2018. The HIV Symptom Index consisted of 20 items evaluating somatic, psychologic, and the combination of both symptoms, and its’ language adaptation to Indonesian was done with Beaton and Guillemin method. Reliability of the Indonesian version of HIV Symptom Index was tested by alpha cronbach’s a coefficient analysis, and the internal validity was tested with multitrait scaling analysis before being used to profile the symptom pattern of HIV/AIDS patients. Results: Indonesian version of HIV Symptom Index is reliable (cronbach alpha 0.76) and valid (multitrait correlation >0.4) for measuring symptoms of HIV/AIDS patients. The most common symptom is fatigue (55.7%), followed by insomnia (43.3%), dizziness and lightheadedness (42.3%), skin problems (42.3%), and pain, numbness, or tingling in the hands or feet (39.2%). Conclusion: Indonesian version of HIV symptom Index is reliable and valid to measure symptoms of HIV/AIDS patiens objectively.


Keywords


symptom; HIV/AIDS; clinical evaluation

References


Ortblad KF, Lozano R, Murray CJL. The burden of HIV: Insights from the global burden of disease study 2010. AIDS. 2013;27(13):2003–17.

WHO 2014. WHO - The top 10 causes of death . Fact sheet N°310 (Updated May 2014). 2014. Available on: http://www.who.int/mediacentre/factsheets/ fs310/en/ pada 10 Oktober 2017.

World Health Organization. Prevalence of HIV among adults aged 15-49 (%). 2013. Available on: http://www.who.int/gho/hiv/epidemic_status/ prevalence/en/ pada 10 Oktober 2017.

UNAIDS. Global AIDS Update 2016. World Health Organization . 2016; March:422. Available on: http://www.unaids.org/sites/default/files/ media_asset/UNAIDS_Gap_report_en.pdf pada 15 Oktober 2017

Justice AC, Holmes W, Gifford AL, et al. Development and validation of a self-completed HIV symptom index. J Clin Epidemiol. 2001;54-12.1.

Whalen CC, Antani M, Carey J, Landefeld CS. An index of symptoms for infection with human immunodeficiency virus: reliability and validity. J Clin Epidemiol. 1994;47(5):537–46.

Justice AC, Chang CH, Rabeneck L, Zackin R. Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care. 2001;39(4):397–408.

Justice AC, Rabeneck L, Hays RD, Wu AW, Bozzette SA, Group OC of the ACT. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. J Acquir Immune Defic Syndr. 1999;21: p. 126–33.

Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian klinis. Jakarta: Sagung Seto; 2011. p. 25–32.

Muhammad NN, Shatri H, Djoerban Z, Abdullah M. Validity and reability test of indonesian version of world health the quality of life patients with HIV/ AIDS Uji Kesahihan dan Keandalan Kuesioner World Health Organization Quality of Life-HIV Bref dalam Bahasa Indonesia untuk Mengukur Kualitas Hidup Pa. J Penyakit Dalam Indones. 2017;4(3):112–8.

Ditjen P2P Kementrian Kesehatan RI. Laporan situasi perkembangan HIV-AIDS dan PIMS di indonesia 2018. Jakarta: Dirjen P2P Kemenkes; 2018. p. 1.

Nokes KM, Kendrew J, Rappaport A, Jordan D, Rivera L. Development of an HIV educational needs assessment tool. J Assoc Nurses AIDS Care. 1997;8(6):46–51.

Murri R, Fantoni M, Borgo C Del, Visona R, Barracco A, Zambelli A. Determinants of health-related quality of life in HIV-infected patients. AIDS Care. 2010;15:4:581–90.

Kilbourne AM, Justice AC, Rollman BL, et al. Clinical importance of HIV and depressive symptoms among veterans with HIV infection. J Gen Intern Med. 2002;17(7):512–20.

Maartens G, Celum C, Lewin SR. HIV infection: Epidemiology, pathogenesis, treatment, and prevention. Lancet. 2014;384(9939):258–71.

Agustriadi O, Sutha IB. Aspek pulmonologis infeksi oportunistik pada infeksi HIV/AIDS. J Peny Dalam. 2008;9(3):233–44.

Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356(9239):1423–30.

Ammassari A, Murri R, Pezzotti P, et al. Self-reported symptoms and medication side-effects influence adherence to highly active antiretroviral therary in persons with HIV infection. Vol. 28, JAIDS. 2001. 445–9.

Scully EP. Sex differences in HIV infection. Curr HIV/AIDS Rep. 2018;15(2):136-46.

Jiang H, Yin J, Fan J, Zhang Z, Liu L, Nie S. Gender difference in advance HIV disease and late presentation according to European consensus definition. Sci Rep. 2015: 5 (1453).


Full Text: PDF

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Acta Medica Indonesiana